| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 64,674 | 61,646 | 53,130 | | Cost of Revenue | 22,849 | 23,433 | 27,094 | | | Gross Profit | 41,825 | 38,213 | 26,036 | | | Operating Expenses | | Research Development | 5,212 | 4,335 | 4,712 | | Selling General and Administrative | 39,680 | 37,596 | 35,657 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,067) | (3,718) | (14,333) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 612 | 3,748 | 4,403 | | Earnings Before Interest And Taxes | (2,455) | 30 | (9,930) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (2,455) | 30 | (9,930) | | Income Tax Expense | 45 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,500) | 30 | (9,930) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,500) | 30 | (9,930) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,500) | $30 | ($9,930) |
|
1.48% Nasdaq 0.00%
Income Statement
